Stock BIVI BIOVIE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar BioVie Inc.

Equities

BIVI

US09074F2074

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
0.4848 USD -0.84% Intraday chart for BioVie Inc. -0.35% -61.52%
03-11 BioVie Inc. Announces Pipeline Update and Near-Term Clinical Priorities CI
03-04 Top Midday Decliners MT

Chart calendar BioVie Inc.

aab97697119b11ebee49ff293d38.W6PsSnW5q1Xufq-R1pmrii9tGrw189VM1KAf1URJ7pE.E5WcFUSI-DTeP-zZ7un0yGYcQtJDg5Ah7MlWgQouqMAd76khQPGfH74v6g~568176b835f927e9f283c6bc3a4f0d0a

Upcoming events on BioVie Inc.

09/05/2024 Q3 2024 Earnings Release (Projected)
12/05/2024 Q1 2025 Earnings Release (Projected)

Past events on BioVie Inc.

09/04/2024 RedChip Investor Group Call
09/03/2024 15:10 Alzheimer and Parkinson Diseases International Conference
08/03/2024 14:50 Alzheimer and Parkinson Diseases International Conference
14/02/2024 17:40 Oppenheimer Healthcare Life Sciences Conference
29/11/2023 13:30 NE3107 Phase 3 Trial Results Call
13/11/2023 18:00 American Association for the Study of Liver Diseases Conference
08/11/2023 18:00 Annual General Meeting
01/11/2023 12:00 Business Update Call
25/10/2023 17:30 Clinical Trials on Alzheimer Disease Conference
26/09/2023 15:30 Cantor Global Healthcare Conference
10/09/2023 American Neurological Association meeting
07/09/2023 19:30 Investor Meeting - Key Opinion Leader
16/07/2023 07:45 Alzheimer Associate International Conference
24/06/2023 19:30 American Diabetes Association Scientific Session - Poster: #1520
11/05/2023 Q3 2023 Earnings Release
25/04/2023 16:45 American Academy of Neurology Meeting - Kaya Jordan
25/04/2023 13:00 American Academy of Neurology Meeting - Joseph Palumbo
23/04/2023 13:00 American Academy of Neurology Meeting - Nilab Osman
01/04/2023 15:00 Alzheimer & Parkinson Disease International Conference
27/03/2023 Alzheimer & Parkinson Disease International Conference

Annual results

Fiscal PeriodJune 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-2,69


-138
-43,5
-217.37%		-27,3
-26,6
-2.35%		-45,1
-47,7
5.58%
-48,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-130
-35,8
-263.82%		-26,1
-28,3
7.7%		-50,3
-55,4
9.27%
-49,4

Net income
Million USD		Released
Forecast
Spread 		0,00


-184
-89,4
-105.65%		-26,1
-27,4
4.87%		-50,3
-55,4
9.27%
-49,4

EPS
USD		Released
Forecast
Spread 		-6,85


-14,8
-7,18
-106.41%		-1,06
-1,12
5.57%		-1,55
-1,76
11.93%
-1,02

Announcement Date06/08/2030/08/2127/09/2216/08/23-

Quarterly results

Fiscal PeriodGiugno 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-6,67
-10,3
35.29%		-5,75
-7,87
26.98%		-9,29
-9,56
2.84%		-8,83
-6,45
-37.07%		-11,5
-9,02
-27.48%		-13,8
-9,90
-39.21%		-11,0
-13,6
19.52%


-8,78
-11,4
22.91%
-12,6


-13,5

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-5,41
-10,9
50.33%		-7,04
-8,18
13.91%		-8,09
-10,3
21.19%		-10,4
-6,84
-52.32%		-15,7
-9,78
-60.36%		-15,0
-11,7
-28.3%		-9,11
-14,2
36.03%


-8,40
-11,9
29.42%
-12,9


-13,7

Net income
Million USD		Released
Forecast
Spread 		-5,41
-10,9
50.33%		-7,04
-8,18
13.91%		-8,09
-9,42
14.15%		-10,4
-6,84
-52.32%		-15,7
-9,78
-60.36%		-15,0
-11,7
-28.3%		-9,11
-14,2
36.03%


-8,40
-11,9
29.42%
-12,9


-13,7

EPS
USD		Released
Forecast
Spread 		-0,22
-0,41
46.34%		-0,28
-0,28
0%		-0,33
-0,37
11.41%		-0,38
-0,29
-33.33%		-0,50
-0,25
-98.02%		-0,43
-0,36
-21.13%		-0,23
-0,40
42.5%		-0,29
-0,31
6.45%		-0,22
-0,28
20%
-0,25


-0,26

Announcement Date08/02/2211/05/2227/09/2204/11/2210/02/2312/05/2316/08/2308/11/2313/02/24--

Upcoming sector events for BioVie Inc.

28/04/2024 HITGEN INC.: Q1 2024 Earnings Release (Projected)
28/04/2024 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
29/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
29/04/2024 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
29/04/2024 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
29/04/2024 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
30/04/2024 21:05 EXELIXIS, INC.: Q1 2024 Earnings Release
30/04/2024 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
30/04/2024 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for BioVie Inc.

25/04/2024 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
25/04/2024 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
25/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
25/04/2024 REMEGEN CO., LTD.: Q1 2024 Earnings Release
25/04/2024 21:05 PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 11:30 SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
24/04/2024 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
24/04/2024 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BIVI Stock
  4. Calendar BioVie Inc.